Nautilus Biotechnology, Inc. (NAUT)

2.67 -0.07 (-2.55%) USD  |  NASDAQ  |  Mar 19, 10:58
More

Nautilus Biotechnology EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for NAUT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Nephros, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade
ProKidney Corp. --
Neumora Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade